
COVID Vaccine Patent Fight Could Shift Costs
The ruling could affect future prices and availability of federally contracted vaccines like Spikevax.
Live Poll
Should drug companies be shielded from patent lawsuits over government-ordered vaccines?
U.S. COVID-19 coverage follows ongoing variants, federal vaccine and booster recommendations, long COVID research and the health policy changes that have followed the acute phase of the pandemic. Reporting takes in preparedness and the legacy questions the pandemic produced.

The ruling could affect future prices and availability of federally contracted vaccines like Spikevax.
Live Poll
Should drug companies be shielded from patent lawsuits over government-ordered vaccines?
November 4, 2026
Pentagon Extends Anthrax Vaccine Supply DealThe contract modification keeps BioThrax doses flowing to military customers, with deliveries set for 2026 and 2027.
November 4, 2026
Norovirus Antiviral Candidate Enters Key TrialAdults who face norovirus, which has no approved drug, may one day have an oral treatment option, though results are not expected until 2026 or 2027.
November 4, 2026
Early Metformin Linked to Lower Long COVID RiskAdults recently infected with COVID-19 saw fewer cases of long COVID or death in an observational U.S. study.
November 3, 2026
Bird Flu Spreads Between Cows, Cats and RaccoonsDairy cows, cats and a raccoon were infected, and pasteurization kills the virus, so heat-treated milk stays safe.
November 3, 2026
Long Covid Recovery Varies Widely by Symptom TypeAdults whose main symptoms are smell or taste changes improved far more often than those with multi-system symptoms over three years.
November 2, 2026
Whistleblower Lawsuit Over Canceled Research ProceedsA federal judge refused to dismiss a fired NIH official's suit, so the case over grant and trial cancellations will move forward in court.
November 2, 2026
One-Swab Test Screens 19 Respiratory PathogensLabs can now run a single nasopharyngeal swab for up to 19 viral and bacterial targets, with results in under two hours.
November 2, 2026
Early H1N1 Flu Wave Hits U.S. Ahead of PeakAdults 50 and older can ask a doctor now whether the new mRNA flu vaccine fits their plans this season.
October 30, 2026
New Pneumococcal Vaccine Shows Promise in Phase 3 TrialA new vaccine candidate for adults over 50 demonstrated broad serotype coverage in recent clinical trial results.
October 30, 2026
Flu Vaccines Recommended As Cases Rise In 44 StatesHealth officials urge everyone six months and older to get vaccinated as flu activity begins rising across the country.
Coverage takes in variant tracking and what surveillance data shows, federal booster and vaccine guidance, long COVID research and what it finds about mechanisms and management, and the policy shifts that have followed the pandemic's acute phase. New York, Los Angeles, Chicago, Houston and Phoenix anchor reporting on where variant activity, clinical research and policy responses draw national attention. Long COVID has become a sustained subject in its own right, given the scale of people affected and the volume of research still in progress. Pandemic preparedness — what infrastructure, funding and planning exists for future outbreaks — runs alongside current outbreak coverage as a distinct strand.